optimer pharmaceuticals inc
(OPTR:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
2013 SEC Filings - optimer pharmaceuticals inc (OPTR)
2012 SEC Filings - optimer pharmaceuticals inc (OPTR)
2011 SEC Filings - optimer pharmaceuticals inc (OPTR)
2010 SEC Filings - optimer pharmaceuticals inc (OPTR)
| Recently Viewed | |||
| OPTR:US | $14.48 USD | -0.19 |  |
| Company | Last | Change |
| Enzon Pharmaceuticals Inc | $3.16 USD | 0.00 |
| Orexigen Therapeutics Inc | $6.45 USD | -0.03 |
| Pfizer Inc | $29.04 USD | -0.07 |
| Synta Pharmaceuticals Corp | $7.57 USD | +0.26 |
| ViroPharma Inc | $27.04 USD | +0.60 |
| View Industry Companies | ||
Industry Analysis
OPTR
Industry Average
| Valuation | OPTR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 6.5x |
|
| Price/Book | 6.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 5.7x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact OPTIMER PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
